| Name | 4,5-dicyanoimidazole |
| Synonyms | DCI ACTIVATOR AURORA 15196 4,5-two -iMidazole 4,5-dicyanoimidazole 4,5-DICYANOIMIDAZOLE 4,5-IMIDAZOLEDICARBONITRILE Imidazole-4,5-dicarbonitrile IMIDAZOLE-4,5-DICARBONITRILE 1H-Imidazole-4,5-dicarbonitrile 1h-imidazole-4,5-dicarbonitrile |
| CAS | 1122-28-7 |
| EINECS | 214-344-6 |
| InChI | InChI=1/C5H2N4/c6-1-4-5(2-7)9-3-8-4/h3H,(H,8,9) |
| InChIKey | XGDRLCRGKUCBQL-UHFFFAOYSA-N |
| Molecular Formula | C5H2N4 |
| Molar Mass | 118.1 |
| Density | 0.791g/mLat 25°C |
| Melting Point | 168-175°C(lit.) |
| Boling Point | 569.3±35.0 °C(Predicted) |
| Flash Point | 50°F |
| Solubility | Soluble in Acetonitrile: 1.8g/10ml, DMSO, Methanol. |
| Vapor Presure | 5.65E-13mmHg at 25°C |
| Appearance | White crystal |
| Color | solid white |
| BRN | 118208 |
| pKa | 5.01±0.10(Predicted) |
| Storage Condition | Inert atmosphere,Room Temperature |
| Refractive Index | 1.584 |
| MDL | MFCD00005194 |
| Physical and Chemical Properties | Melting point 168-175°C |
| Use | Used as an intermediate in organic synthesis |
| Risk Codes | R37/38 - Irritating to respiratory system and skin. R41 - Risk of serious damage to eyes R36/37/38 - Irritating to eyes, respiratory system and skin. R20/22 - Harmful by inhalation and if swallowed. R36 - Irritating to the eyes R20/21/22 - Harmful by inhalation, in contact with skin and if swallowed. R11 - Highly Flammable |
| Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S39 - Wear eye / face protection. S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection. S36/37 - Wear suitable protective clothing and gloves. S16 - Keep away from sources of ignition. |
| UN IDs | UN 1648 3/PG 2 |
| WGK Germany | 3 |
| HS Code | 29332900 |
| Hazard Note | Irritant |
| Hazard Class | 6.1 |
| Packing Group | III |
| use | as raw material for medicine, or organic synthesis. Used as an intermediate in organic synthesis Nucleoside phosphoramidite activator for low nucleotide synthesis polypeptide synthesis. |